Nuvalent

NUVL | NASDAQ | 0 Obserwujący

$80.97

-0.65%

-$0.53

Obserwuj

Overview Metrics Financials

Fair Price

$54.47

Overvalued by 62.9%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Nuvalent is a biotechnology company focused on developing targeted therapies for the treatment of advanced cancers. The company uses advanced technologies to create specific drugs that target molecular mechanisms within cancer cells, increasing treatment effectiveness and minimizing side effects. Nuvalent focuses on developing therapeutics for cancers with specific genetic mutations, such as lung cancer, and strives to provide new treatment options for patients.

Feed

There are no posts to show right now.

Nuvalent

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?